跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MONTELUKAST VIATRIS montelukast 5 mg (as sodium) chewable tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
MONTELUKAST VIATRIS montelukast 5 mg (as sodium) chewable tablet blister pack
Approved
STANDARD
MONTELUKAST VIATRIS montelukast 5 mg (as sodium) chewable tablet blister pack
Accord Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
3c7770aa257a021b
Company
Accord Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
3c7770aa257a021b
Product Name
MONTELUKAST VIATRIS montelukast 5 mg (as sodium) chewable tablet blister pack
Artg Id
323025
Artg Name
MONTELUKAST VIATRIS montelukast 5 mg (as sodium) chewable tablet blister pack
Sponsor
Accord Healthcare Pty Ltd
Company Detail Path
/organization/accord-healthcare-pty-ltd
Artg Date
2019-11-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-02180-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01059-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
3c7770aa257a021b
Type
Standard
Back to TGA Approvals